Skip to main content
Caplight Logo









Torus Biosystems

Torus Biosystems

Private
Medford, MassachusettsHealthcare & Life Scienceshttps://torus.bio

Last Round

Series A

May 26, 2021

Total Funding Raised

$28.8M

Company Overview

Torus Biosystems is a biotechnology company that develops rapid, point-of-care syndromic diagnostic testing solutions for infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care diagnosticsmolecular diagnosticsPOC testinginfectious disease testingqPCRmultiplexed diagnosticsdiagnostic platformnucleic acid detectionmedical deviceantimicrobial stewardshiplab-on-a-chiprapid testingdiagnostic consumablesresearch-use-onlyRUO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Torus Biosystems Comparables

Compare Torus Biosystems with similar companies based on industry and business-model similarity.

Torus Biosystems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
binx health
81%
QuantuMDx
80%
Danaher Corporation
76%

Torus Biosystems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 26, 2021
GrantJan 13, 2021
Convertible DebtDec 29, 2020
SeedFeb 7, 2020

Key People

Founding team and executive leadership

Eva Miao

Chief Financial Officer

Executive Team

Torus Biosystems Investors

Notable investors and investment history

Torus Biosystems investors
InvestorRounds
NIH RADxGrant
Northpond VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2021

    $25M round led by Northpond Ventures.

  • Jan 13, 2021

    $300K awarded by NIH RADx

Torus Biosystems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Torus Biosystems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Torus Biosystems's valuation, stock price, and market status.

Firmographic Details

HeadquartersMedford, Massachusetts
Employee Range3
Year Founded2019
Last FundingMay 26, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?